- Moderna prices new shares at $76, expects to raise $1.34 billion CNBC
- Early results from Moderna coronavirus vaccine trial show participants developed antibodies against the virus CNN
- Coronavirus Updates: Trump Taking Unproven Hydroxychloroquine; Moderna Vaccine Shows Early Promise Bloomberg QuickTake
- Vaccine Developers Like Moderna Need to Take Their Time Bloomberg
- Vaccine hopes drive Asian stocks, oil higher, but risks remain Aljazeera.com
- View Full Coverage on Google News
Source: Google News | Moderna prices new shares at , expects to raise .34 billion – CNBC
No Comments